Samsung Biologics Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Samsung Biologics Co Ltd

Watchlist Manager

Watchlist

Price: 1 415 000 KRW -0.56% Market Closed

Market Cap: ₩65.5T

	Samsung Biologics Co Ltd KRX:207940	KR
	Netscout Systems Inc NASDAQ:NTCT	US
M	MarineMax Inc F:MLW	US
	Lemonade Inc LSE:0A91	US
F	Franklin Resources Inc XMUN:FRK	US
	CapitaLand Integrated Commercial Trust SGX:C38U	SG
C	CDL Hospitality Trusts SGX:J85	SG
B	Bank Central Asia Tbk PT OTC:PBCRF	ID
G	Grupo Aeroportuario del Centro Norte SAB De CV XMUN:G7A	MX
	Prologis Inc NYSE:PLD	US
E	EnerSys SWB:FDN	US
	Oriental Land Co Ltd F:OLL	JP
D	Deutsche Post AG F:DPW	DE
C	Campbell's Co DUS:CSC	US

Profitability Summary

Samsung Biologics Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

54%

Strong 3Y Average Gross Margin

52%

Gross Margin is Increasing

50% > 54%

Exceptional Operating Margin

50%

Strong 3Y Average Operating Margin

35%

Operating Margin is Increasing

32% > 50%

Exceptional Net Margin

44%

Sustainable 3Y Average Net Margin

29%

Net Margin is Increasing

24% > 44%

Exceptional Free Cash Flow Margin

35%

Strong 3Y Average Free Cash Flow Margin

17%

Free Cash Flow Margin is Increasing

4% > 35%

Positive ROE

20%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.